Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.74 CAD | +0.79% |
|
+8.70% | -4.10% |
Jul. 10 | Raymond James Initiates Bausch + Lomb at Outperform Rating With $19 Price Target | MT |
Jul. 08 | RBC Capital on Bausch + Lomb's Miebo, Xiidra, Prescription Numbers | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BLCO Stock
- BLCO Stock
- Charts Bausch + Lomb Corporation